Search
MN-246
go.drugbank.com/drugs/DB05981ExperimentalMN-246 is a novel ß3-adrenergic receptor agonist developed for the treatment of urinary incontinence by MediciNova Inc.
Sinecatechins
go.drugbank.com/drugs/DB01266ApprovedInvestigationalNutraceuticalIt is a partially purified fraction of the water extract of green tea leaves from Camellia sinensis, and is a mixture of catechins and other green tea components. … Sinecatechins is a botanical drug product for topical use.
Pradefovir mesylate
go.drugbank.com/drugs/DB05478InvestigationalPradefovir is undergoing phase II development for the treatment of chronic hepatitis B. … Pradefovir is activated through oxidation that is mediated by cytochrome P-450 (CYP) 3A4, which is predominantly expressed in the liver.
Fallypride
go.drugbank.com/drugs/DB15167InvestigationalFallypride is under investigation in clinical trial NCT02310360 (Striatal and Extra-striatal Dopamine Release in Response to Food in Healthy Humans).
Categories: Dopamine D2 Receptor AntagonistsHydroxytyrosol
go.drugbank.com/drugs/DB12771InvestigationalHydroxytyrosol has been used in trials studying the prevention of Breast Cancer.
Categories: Compounds used in a research, industrial, or household settingZidebactam
go.drugbank.com/drugs/DB13090ApprovedZidebactam is a diazabicyclooctane that acts both as a beta-lactamase inhibitor and as an antibacterial in its own right, selectively binding penicillin-binding protein 2. … [L63350] It is available only in fixed combination with [cefepime], which binds PBP3 and PBP1a/b.
Allylestrenol
go.drugbank.com/drugs/DB01431Investigationalnotably not in the United States or Canada. … A synthetic steroid with progestational activity.
Synonyms: 17α-allylestr-4-en-17β-olAmilomotide
go.drugbank.com/drugs/DB05150InvestigationalCAD106 is an immunotherapeutic product in development for the treatment of Alzheimer's disease. … It is designed to induce antibodies against the beta-amyloid-protein that inhibit the formation of plaques in the brain of Alzheimer's disease patients.